Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more
Krsnaa Diagnostics Limited (KRSNAA) - Total Liabilities
Latest total liabilities as of September 2025: ₹5.84 Billion INR
Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has total liabilities worth ₹5.84 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Krsnaa Diagnostics Limited - Total Liabilities Trend (2017–2025)
This chart illustrates how Krsnaa Diagnostics Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Krsnaa Diagnostics Limited Competitors by Total Liabilities
The table below lists competitors of Krsnaa Diagnostics Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seven Hills Realty Trust
NASDAQ:SEVN
|
USA | $434.36 Million |
|
Guararapes Confecções S.A
SA:GUAR3
|
Brazil | R$8.01 Billion |
|
Mold-Tek Packaging Limited
NSE:MOLDTKPAC
|
India | ₹3.51 Billion |
|
West Shanghai Automotive Service Co.Ltd.
SHG:605151
|
China | CN¥1.39 Billion |
|
Inozyme Pharma Inc
NASDAQ:INZY
|
USA | $63.37 Million |
|
LaFayette Acquisition Corp. Ordinary Share
NASDAQ:LAFA
|
USA | $340.23K |
|
Canton Strategic Holdings, Inc.
NASDAQ:CNTN
|
USA | $1.54 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Krsnaa Diagnostics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Krsnaa Diagnostics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Krsnaa Diagnostics Limited (2017–2025)
The table below shows the annual total liabilities of Krsnaa Diagnostics Limited from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹3.99 Billion | +10.14% |
| 2024-03-31 | ₹3.62 Billion | +111.57% |
| 2023-03-31 | ₹1.71 Billion | -17.49% |
| 2022-03-31 | ₹2.07 Billion | -44.34% |
| 2021-03-31 | ₹3.73 Billion | -54.94% |
| 2020-03-31 | ₹8.27 Billion | +34.70% |
| 2019-03-31 | ₹6.14 Billion | +93.54% |
| 2018-03-31 | ₹3.17 Billion | +217.46% |
| 2017-03-31 | ₹999.19 Million | -- |